Bendamustine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bendamustine" in English language version.

refsWebsite

Global rank English rank

6web.archive.org

1^st place

5doi.org

2^nd place

5nih.gov

4^th place

2tga.gov.au

3,984^th place

2,622^nd place

2handle.net

102^nd place

76^th place

2semanticscholar.org

11^th place

8^th place

2cephalon.com

low place

1drugs.com

399^th place

333^rd place

1medpagetoday.com

9,274^th place

5,856^th place

1usnews.com

634^th place

432^nd place

1unal.edu.co

4,585^th place

8,271^st place

cephalon.com

"Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia". Cephalon press release. Archived from the original on 21 April 2008. Retrieved 23 March 2008.
"Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma". Cephalon press release. Archived from the original on 7 December 2008. Retrieved 3 November 2008.

doi.org

Dubbelman AC, Rosing H, Darwish M, D'Andrea D, Bond M, Hellriegel E, et al. (March 2013). "Pharmacokinetics and excretion of 14C-bendamustine in patients with relapsed or refractory malignancy". Drugs in R&D. 13 (1): 17–28. doi:10.1007/s40268-012-0001-5. PMC 3627029. PMID 23322528.
Weide R, Hess G, Köppler H, Heymanns J, Thomalla J, Aldaoud A, et al. (July 2007). "High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG)". Leukemia & Lymphoma. 48 (7): 1299–1306. doi:10.1080/10428190701361828. PMID 17613757. S2CID 2381354.
Tageja N, Nagi J (August 2010). "Bendamustine: something old, something new" (PDF). Cancer Chemotherapy and Pharmacology. 66 (3): 413–423. doi:10.1007/s00280-010-1317-x. PMID 20376452. S2CID 25605764.
Ozegowski W, Krebs D (June 1963). "Aminosäureantagonisten. III. ω-[Bis-(β-chloräthyl)-amino-benzimidazolyl-(2)]-propion- bzw. -buttersäuren als potentielle Cytostatika". Advanced Synthesis and Catalysis. 20 (3–4): 178–186. doi:10.1002/prac.19630200310.
Bagchi S (August 2007). "Bendamustine for advanced sarcoma". The Lancet. Oncology. 8 (8): 674. doi:10.1016/S1470-2045(07)70225-5. PMID 17726779.

drugs.com

"Bendamustine Hydrochloride". The American Society of Health-System Pharmacists. Archived from the original on 21 December 2016. Retrieved 8 December 2016.

handle.net

hdl.handle.net

World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.

medpagetoday.com

Susman E (December 2012). Zaleznik DF (ed.). "New Combo Replaces CHOP for Lymphoma". MedPageToday. Archived from the original on 11 September 2014.

nih.gov

pubmed.ncbi.nlm.nih.gov

Dubbelman AC, Rosing H, Darwish M, D'Andrea D, Bond M, Hellriegel E, et al. (March 2013). "Pharmacokinetics and excretion of 14C-bendamustine in patients with relapsed or refractory malignancy". Drugs in R&D. 13 (1): 17–28. doi:10.1007/s40268-012-0001-5. PMC 3627029. PMID 23322528.
Weide R, Hess G, Köppler H, Heymanns J, Thomalla J, Aldaoud A, et al. (July 2007). "High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG)". Leukemia & Lymphoma. 48 (7): 1299–1306. doi:10.1080/10428190701361828. PMID 17613757. S2CID 2381354.
Tageja N, Nagi J (August 2010). "Bendamustine: something old, something new" (PDF). Cancer Chemotherapy and Pharmacology. 66 (3): 413–423. doi:10.1007/s00280-010-1317-x. PMID 20376452. S2CID 25605764.
Bagchi S (August 2007). "Bendamustine for advanced sarcoma". The Lancet. Oncology. 8 (8): 674. doi:10.1016/S1470-2045(07)70225-5. PMID 17726779.

ncbi.nlm.nih.gov

Dubbelman AC, Rosing H, Darwish M, D'Andrea D, Bond M, Hellriegel E, et al. (March 2013). "Pharmacokinetics and excretion of 14C-bendamustine in patients with relapsed or refractory malignancy". Drugs in R&D. 13 (1): 17–28. doi:10.1007/s40268-012-0001-5. PMC 3627029. PMID 23322528.

semanticscholar.org

api.semanticscholar.org

Weide R, Hess G, Köppler H, Heymanns J, Thomalla J, Aldaoud A, et al. (July 2007). "High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG)". Leukemia & Lymphoma. 48 (7): 1299–1306. doi:10.1080/10428190701361828. PMID 17613757. S2CID 2381354.
Tageja N, Nagi J (August 2010). "Bendamustine: something old, something new" (PDF). Cancer Chemotherapy and Pharmacology. 66 (3): 413–423. doi:10.1007/s00280-010-1317-x. PMID 20376452. S2CID 25605764.

tga.gov.au

"Prescription medicines: registration of new chemical entities in Australia, 2014". Therapeutic Goods Administration (TGA). 21 June 2022. Archived from the original on 10 April 2023. Retrieved 10 April 2023.
"Bendamustine EPSL (Eugia Pharma (Australia) Pty Ltd)". Therapeutic Goods Administration (TGA). 13 March 2025. Retrieved 24 March 2025.

unal.edu.co

repositorio.unal.edu.co

Tageja N, Nagi J (August 2010). "Bendamustine: something old, something new" (PDF). Cancer Chemotherapy and Pharmacology. 66 (3): 413–423. doi:10.1007/s00280-010-1317-x. PMID 20376452. S2CID 25605764.

usnews.com

health.usnews.com

Mundell EJ (3 June 2012). "'Rediscovered' Lymphoma Drug Helps Double Survival: Study". U.S. News & World Report. Archived from the original on 12 July 2012.

web.archive.org

"Prescription medicines: registration of new chemical entities in Australia, 2014". Therapeutic Goods Administration (TGA). 21 June 2022. Archived from the original on 10 April 2023. Retrieved 10 April 2023.
"Bendamustine Hydrochloride". The American Society of Health-System Pharmacists. Archived from the original on 21 December 2016. Retrieved 8 December 2016.
Susman E (December 2012). Zaleznik DF (ed.). "New Combo Replaces CHOP for Lymphoma". MedPageToday. Archived from the original on 11 September 2014.
Mundell EJ (3 June 2012). "'Rediscovered' Lymphoma Drug Helps Double Survival: Study". U.S. News & World Report. Archived from the original on 12 July 2012.
"Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia". Cephalon press release. Archived from the original on 21 April 2008. Retrieved 23 March 2008.
"Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma". Cephalon press release. Archived from the original on 7 December 2008. Retrieved 3 November 2008.